-
Likelihood of Approval and Phase Transition Success Rate Model - Epacadostat in Dedifferentiated Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Epacadostat in Dedifferentiated Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epacadostat in Dedifferentiated Liposarcoma Drug Details: Epacadostat (INCB-24360) is under development...
-
Likelihood of Approval and Phase Transition Success Rate Model - AHT-434 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AHT-434 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AHT-434 in Multiple...
-
Likelihood of Approval and Phase Transition Success Rate Model - Reparixin in Coronavirus Disease 2019 (COVID-19) Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Reparixin in Coronavirus Disease 2019 (COVID-19) Pneumonia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Reparixin in Coronavirus Disease 2019 (COVID-19) Pneumonia Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab in Acute Myelocytic Leukemia (AML,...
-
Likelihood of Approval and Phase Transition Success Rate Model - Fostamatinib Disodium in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fostamatinib Disodium in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fostamatinib Disodium in Coronavirus Disease 2019 (COVID-19) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Solriamfetol Hydrochloride in Shift Work Sleep Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Solriamfetol Hydrochloride in Shift Work Sleep Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Solriamfetol Hydrochloride in Shift Work Sleep Disorder Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Lipocurc in Metastatic Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lipocurc in Metastatic Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipocurc in Metastatic Prostate Cancer Drug Details: Lipocurc is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Angiosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Angiosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel in Angiosarcoma Drug Details: Paclitaxel (DHP-107, Liporaxel, Paclitaxel) is a taxane...
-
Likelihood of Approval and Phase Transition Success Rate Model - Sonidegib Phosphate in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sonidegib Phosphate in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sonidegib Phosphate in Hepatocellular Carcinoma Drug Details: Sonidegib phosphate (Odomzo)...
-
Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Oral Cavity (Mouth) Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab in Oral Cavity (Mouth) Cancer Drug Details: Nivolumab...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.